Webinar 74 – AIOS ARC – PG UPDATE SERIES IN UVEA DEBATES WITH A QUEST – AIOS ARC

DO ALL PATIENTS WITH INTERMEDIATE UVEITIS NEED TREATMENT? FOR DR. MUDIT TYAGI

DO ALL PATIENTS WITH INTERMEDIATE UVEITIS NEED TREATMENT? AGAINST DR. REEMA BANSAL

DOES VITRECTOMY ITSELF IN INTERMEDIATE UVEITIS HAVE A THERAPEUTIC ROLE? FOR DR.SOUMYAVA BASU

DOES VITRECTOMY ITSELF IN INTERMEDIATE UVEITIS HAVE A THERAPEUTIC ROLE? AGAINST DR.SUDHARSHAN S.

WHAT IS THE TREATMENT TARGET FOR THE UVEITIS: NO INFLAMMATION OR IS MILD INFLAMMATION OK? FOR DR.PADMAMALINI MAHENDRA DAS

WHAT IS THE TREATMENT TARGET FOR THE UVEITIS: NO INFLAMMATION OR IS MILD INFLAMMATION OK? AGAINST DR. KALPANA BABU MURTHY

DO PATIENTS WITH HLA B 27 ASSOCIATED UVEITIS REQUIRES IMMUNOMODULATION? FOR DR. PARTHAPRATIM DUTTA MAJUMDER

DO PATIENTS WITH HLA B 27 ASSOCIATED UVEITIS REQUIRES IMMUNOMODULATION? AGAINST DR. S. BALA MURUGAN

DO ALL PATIENTS WITH INTRAOCULAR TB REQUIRES CO ADMINISTRATION OF ORAL CORTICOSTEROIDS WITH ATT? FOR DR.SHARANYA ABRAHAM

DO ALL PATIENTS WITH INTRAOCULAR TB REQUIRES CO ADMINISTRATION OF ORAL CORTICOSTEROIDS WITH ATT? AGAINST DR. SAI BHAKTI MISHRA

FFA VS ICG IN DIAGNOSIS OF UVEITIS? FOR FFA DR.ANAMIKA PATEL

FFA VS ICG IN DIAGNOSIS OF UVEITIS? FOR ICG DR.ANUP KELGAONKAR

ORAL VALGANCYCLOVIR OR INTRAVITREAL GANCYCLOVIR IN THE MANAGEMENT OF CMV RETINITIS FOR VALGANCYCLOVIR DR.MEGHA GULATI

ORAL VALGANCYCLOVIR OR INTRAVITREAL GANCYCLOVIR IN THE MANAGEMENT OF CMV RETINITIS AGAINST DR. MALLIKA GOYAL

IOL WITH INTRAVITREAL STEROID VS IOL WITHOUT INTRAVITREAL STEROID IN THE MANAGEMENT OF COMPLICATED CATARACT POST UVEITIS FOR DR. KETAN SAOJI

IOL WITH INTRAVITREAL STEROID VS IOL WITHOUT INTRAVITREAL STEROID IN THE MANAGEMENT OF COMPLICATED CATARACT POST UVEITIS AGAINST DR.THENARASUN SEETHALAKSHMI ASAITHAMBI